William O. Wilkison

8.4k citations

30 papers · 7.1k indexed · 3 hit papers · h-index 24

Molecular Biology top 2%
Physiology top 1%
Nutrition and Dietetics top 0.5%
Epidemiology top 2%
Endocrine and Autonomic Systems top 0.5%

Co-authors: Steven A. Kliewer Jürgen M. Lehmann Timothy M. Willson Linda B. Moore Tracey Smith-Oliver Jeffrey M. Gimble Yuan‐Di C. Halvorsen Derril H. Willard
Topics: Adipose Tissue and Metabolism (9 papers)melanin and skin pigmentation (8 papers)Regulation of Appetite and Obesity (8 papers)
Cited by: Endocrine and Autonomic Systems Genetics Physiology
Journals: Nature Cell Journal of Biological Chemistry
Partner nations: United States New Zealand Switzerland

In The Last Decade

William O. Wilkison

30 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)

1995 3.1k citations Jürgen M. Lehmann, Linda B. Moore et al. Journal of Biological Chemistry profile →
Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor

1994 851 citations Dongsi Lu, Derril H. Willard et al. Nature profile →
Neurogenic differentiation of murine and human adipose-derived stromal cells

2002 628 citations Kristine M. Safford, Kevin C. Hicok et al. Biochemical and Biophysical Research Communications profile →

Peers

Countries citing papers authored by William O. Wilkison

Since Specialization

Citations

This map shows the geographic impact of William O. Wilkison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William O. Wilkison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William O. Wilkison more than expected).

Fields of papers citing papers by William O. Wilkison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William O. Wilkison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William O. Wilkison. The network helps show where William O. Wilkison may publish in the future.

Co-authorship network of co-authors of William O. Wilkison

This figure shows the co-authorship network connecting the top 25 collaborators of William O. Wilkison. A scholar is included among the top collaborators of William O. Wilkison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William O. Wilkison. William O. Wilkison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FRI605 Inhibition Of Intestinal SGLT1 With Mizagliflozin For The Treatment Of Post-bariatric Hypoglycemia 2023 ·Journal of the Endocrine Society ·(unknown),Tracey McLaughlin,Soroush Shakeri,(unknown),(unknown),(unknown),(unknown),Susan Walker,Bentley Cheatham,William O. Wilkison	2
2	Pharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor Remogliflozin Etabonate in Subjects with Mild and Moderate Renal Impairment 2015 ·Drug Metabolism and Disposition ·Robin O'Connor‐Semmes,Susan Walker,Anita Kapur,Elizabeth K. Hussey,June Ye,(unknown),(unknown),Robert L. Dobbins,Bentley Cheatham,William O. Wilkison	13
3	Liver-specific expression of the agouti gene in transgenic mice promotes liver carcinogenesis in the absence of obesity and diabetes. 2004 ·Molecular Cancer ·A. I. Kuklin,Randall L. Mynatt,Mitchell Klebig,Laura L. Kiefer,William O. Wilkison,Richard P. Woychik,Edward J. Michaud	10
4	Neurogenic differentiation of murine and human adipose-derived stromal cellsbreakdown → 2002 ·Biochemical and Biophysical Research Communications ·Kristine M. Safford,Kevin C. Hicok,Shawn D. Safford,(unknown),William O. Wilkison,Jeffrey M. Gimble,Henry E. Rice	628
5	Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous 2001 ·Journal of Cellular Biochemistry ·Anindita Sen,Y. Reneé Lea-Currie,(unknown),Dawn M. Franklin,William O. Wilkison,Yuan‐Di C. Halvorsen,Jeffrey M. Gimble	213
6	Identification of a subtype selective human PPARα agonist through parallel-array synthesis 2001 ·Bioorganic & Medicinal Chemistry Letters ·Peter J. Brown,(unknown),(unknown),Michael C. Lewis,Deborah A. Winegar,Joan G. Wilson,William O. Wilkison,Olivia Ittoop,Timothy M. Willson	153
7	Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: Biochemical, cellular, and molecular analysis 2001 ·Metabolism ·Yuan‐Di C. Halvorsen,(unknown),Anindita Sen,Dawn M. Franklin,Y. Reneé Lea-Currie,(unknown),(unknown),William O. Wilkison,Jeffrey M. Gimble	165
8	Extracellular Matrix Mineralization and Osteoblast Gene Expression by Human Adipose Tissue–Derived Stromal Cells 2001 ·Tissue Engineering ·Yuan‐Di C. Halvorsen,Dawn M. Franklin,(unknown),(unknown),(unknown),Adele L. Boskey,Eleftherios P. Paschalis,William O. Wilkison,Jeffrey M. Gimble	415
9	Human adipocyte proteomics - a complementary way of looking at fat 2000 ·Pharmacogenomics ·Yuan‐Di C. Halvorsen,William O. Wilkison,Michael R. Briggs	14
10	Role of intracellular calcium in human adipocyte differentiation 2000 ·Physiological Genomics ·Hang Shi,Yuan‐Di C. Halvorsen,(unknown),William O. Wilkison,Michael B. Zemel	173
11	Thiazolidinedione Exposure Increases the Expression of Uncoupling Protein 1 in Cultured Human Preadipocytes 1998 ·Diabetes ·Janet E. Digby,Elizabeth Montague,Ciaran Sewter,Louise Sanders,William O. Wilkison,Stephen O’Rahilly,Johannes B. Prins	121
12	Interactions of α-Melanotropin and Agouti on B16 Melanoma Cells: Evidence for Inverse Agonism of Agouti 1997 ·Journal of Receptors and Signal Transduction ·Walter Siegrist,(unknown),(unknown),Derril H. Willard,William O. Wilkison,(unknown)	69
13	Linkage and Association Studies between the Melanocortin Receptors 4 and 5 Genes and Obesity-Related Phenotypes in the Québec Family Study 1997 ·Molecular Medicine ·Marie‐Christine Chagnon,Wenji Chen,Louis Përusse,André Nadeau,William O. Wilkison,Claude Bouchard	129
14	sn-Glycerol-3-phosphate acyltransferase from Escherichia coli 1997 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·William O. Wilkison,Robert M. Bell	26
15	Activation of the Nuclear Receptor Peroxisome Proliferator-activated Receptor γ Promotes Brown Adipocyte Differentiation 1996 ·Journal of Biological Chemistry ·(unknown),(unknown),Kathleen K. Brown,(unknown),(unknown),William O. Wilkison,H. Roger Brown,Jürgen M. Lehmann,Steven A. Kliewer,David C. Morris,Reed A. Graves	141
16	Agouti Protein Inhibits Growth of B16 Melanoma Cellsin Vitroby Acting through Melanocortin Receptors 1996 ·Biochemical and Biophysical Research Communications ·Walter Siegrist,Derril H. Willard,William O. Wilkison,Alex N. Eberlé	41
17	An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)breakdown → 1995 ·Journal of Biological Chemistry ·Jürgen M. Lehmann,Linda B. Moore,Tracey Smith-Oliver,William O. Wilkison,Timothy M. Willson,Steven A. Kliewer	3145
18	Agouti Antagonism of Melanocortin Binding and Action in the B16F10 Murine Melanoma Cell Line 1995 ·Biochemistry ·Steven G. Blanchard,(unknown),Olivia Ittoop,James S. Nichols,Derek J. Parks,Anne T. Truesdale,William O. Wilkison	60
19	Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptorbreakdown → 1994 ·Nature ·Dongsi Lu,Derril H. Willard,Indravadan R. Patel,Sue H. Kadwell,Laurie K. Overton,(unknown),Michael Luther,(unknown),Richard P. Woychik,William O. Wilkison,Roger D. Cone	851
20	Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA 1988 ·Cell ·Derek A. Persons,William O. Wilkison,Robert M. Bell,Olivera J. Finn	263

About William O. Wilkison

William O. Wilkison is a scholar working on Endocrine and Autonomic Systems, Nutrition and Dietetics and Biochemistry, having authored 30 papers that have together received 7.1k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (9 papers), melanin and skin pigmentation (8 papers) and Regulation of Appetite and Obesity (8 papers). The work is most often cited by research in Endocrine and Autonomic Systems (1.1k citations), Genetics (1.1k citations) and Physiology (2.0k citations). William O. Wilkison has collaborated with scholars based in United States, New Zealand and Switzerland. Frequent co-authors include Steven A. Kliewer, Jürgen M. Lehmann, Timothy M. Willson, Linda B. Moore, Tracey Smith-Oliver, Jeffrey M. Gimble, Yuan‐Di C. Halvorsen, Derril H. Willard, Dawn M. Franklin and Shawn D. Safford. Their work appears in journals such as Nature, Cell and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact